CoChat

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization

Open access

Abstract

The original Riva-Rocci method to measure blood pressure (BP) using a cuff at the upper arm assumed the pressure obtained by this technique was a good proxy for central aortic BP.1,2 The clinical (prognostic) importance of brachial cuff BP is undeniable for both the assessment of cardiovascular risk associated with elevated BP and the benefits of treatment-induced BP reduction.3 However, it is also generally appreciated that peripheral artery systolic BP (SBP; brachial or radial artery) may be an inaccurate substitute for central SBP.4 This has been reported in human studies using intra-arterial catheterization of peripheral and central arteries.5–8 There may also be a discrepancy between peripheral and central BP responses to vasoactive drugs.9 These findings are corroborated in larger studies using non-invasive central aortic BP methods,10–13 and, while yet to be fully adopted in clinical practice, an independent prognostic value of central BP has been demonstrated.14–16 Altogether, there is a growing interest among clinicians towards improving risk estimates by using devices that provide more accurate measures of central aortic BP than those provided by current brachial cuff BP methods. Many non-invasive devices have been developed that purport to estimate central BP from different peripheral artery sites (e.g. radial, brachial, carotid arteries) using different principles of recording the pressure or surrogate signals (e.g. applanation tonometry, oscillometry, ultrasound, or magnetic resonance imaging) and different calibration methods to derive central BP. Since upper arm cuff-based devices to estimate central BP are more clinically appealing, in recent years several companies have developed such devices using a variety of techniques (e.g. oscillometric sub-diastolic or supra-systolic waveform analysis with generalized transfer functions), which employ a variety of signal processing steps to estimate central BP from peripheral signals.17,18 Yet, with no standardized guidelines,17 the accuracy testing of these new devices (as well as the preceding devices) has not been undertaken in a uniform fashion with comparable protocols, emphasizing the need for guidance in this field.19–22 An international task force was convened to address this situation. To identify issues that need to be addressed and reach consensus relating to methods for assessing and reporting the accuracy of central BP devices. To provide recommendations regarding appropriate protocols to assess and report the evaluation of accuracy (validation) of central BP devices. Initiation of the task force emanated from issues raised at an organized debate relating to central BP at the ARTERY Society Meeting, Maastricht, The Netherlands in October 2014. Task force members were invited to provide feedback on a draft document of intent prior to the first meeting at the ESH Meeting, Milan, Italy, June 2015. At this meeting, terms of reference, principal issues, and topics were refined. A second meeting to discuss outstanding issues was held at the 2015 ARTERY Society meeting, Krakow, Poland, with communication of upgraded documents to members for input, and with disagreements settled by majority consensus. Identified issues and recommendations (a glossary of terms is provided in Table 1): Glossary of terms Glossary of terms (1) Disparity of non-invasive central BP devices as to what is being measured. Most central BP devices claim to produce an estimated central BP relative to cuff brachial BP with brachial SBP usually higher than central SBP. This can be achieved by a variety of techniques including: (a) Brachial forearm or radial applanation tonometry and a peripheral waveform-aorta transfer function23 or the radial waveform second systolic peak.24 (b) Local derivation of carotid BP on the assumption that with appropriate waveform calibration (i.e. mean arterial pressure [MAP] and diastolic BP [DBP]) carotid BP represents central aortic BP. This can be achieved by non-invasive carotid artery tonometry or ultrasound/magnetic resonance imaging of the carotid diameter/area waveform.25–27 (similar techniques are also being applied on aortic distension waveforms).28 However, for practical applications, the radial or brachial artery waveform is more readily recorded where waveforms are registered with more consistent reproducibility and repeatability, and are less prone to noise introduced by incorrect vessel applanation or respiration as can occur with carotid waveforms. (c) Calculated central BP through transfer function and modified calibration of peripheral pressure waveforms.26,29,30 Methods (b) or (c) may produce central SBP estimates higher than brachial cuff SBP (discussed within issue 2). (i) Recommendations: Device manufacturers should clearly state the purported measurement function of their device. While recognizing wide variety in devices, these can be broadly categorized into two types based on their function: Type I—device purports to give

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw632

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Illustration of the differences in systolic (SBP) and diastolic (DBP) blood pressure (BP) between intra-arterial brachial and central BP, brachial cuff BP, and non-invasive central BP devices Types I and II (BP ranges of different methods represented by the double arrows). Red shaded area A, represents the true (intra-arterial) level of central-to-brachial SBP amplification, and red shaded area B represents the non-invasive estimated central-to-brachial SBP amplification (A and B may be similar in magnitude). The non-invasive central SBP estimated using central BP device Type II may be higher than non-invasive brachial cuff SBP, but this is due to underestimation of true (intra-arterial) brachial SBP with the cuff device and, therefore, does not reflect physiological amplification. The hatched areas denote that there will be a degree of variability in estimated BP between devices.
Figure 1 Illustration of the differences in systolic (SBP) and diastolic (DBP) blood pressure (BP) between intra-arterial brachial and central BP, brachial cuff BP, and non-invasive central BP devices Types I and II (BP ranges of different methods represented by the double arrows). Red shaded area A, represents the true (intra-arterial) level of central-to-brachial SBP amplification, and red shaded area B represents the non-invasive estimated central-to-brachial SBP amplification (A and B may be similar in magnitude). The non-invasive central SBP estimated using central BP device Type II may be higher than non-invasive brachial cuff SBP, but this is due to underestimation of true (intra-arterial) brachial SBP with the cuff device and, therefore, does not reflect physiological amplification. The hatched areas denote that there will be a degree of variability in estimated BP between devices.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 2

  1. O’Brien, 1993, The British Hypertension Society protocol for the evaluation of blood pressure measuring devices, J Hypertens, 11 (Suppl 2), S43
  2. Review of the Australian Code for the Responsible Conduct of Research, 2007

Cited by

See all 231

Metadata

Authors
Sharman, J. E., Avolio, A. P., Baulmann, J., Benetos, A., Blacher, J., Blizzard, C. L., Boutouyrie, P., Chen, C.-H., Chowienczyk, P., Cockcroft, J. R., Cruickshank, J. K., Ferreira, I., Ghiadoni, L., Hughes, A., Jankowski, P., Laurent, S., McDonnell, B. J., McEniery, C., Millasseau, S. C., Papaioannou, T. G., Parati, G., Park, J. B., Protogerou, A. D., Roman, M. J., Schillaci, G., Segers, P., Stergiou, G. S., Tomiyama, H., Townsend, R. R., Van Bortel, L. M., Wang, J., Wassertheurer, S., Weber, T., Wilkinson, I. B., & Vlachopoulos, C.
Affiliations
  • University of Tasmania (AU)
  • Macquarie University (AU)
  • University Hospital Schleswig-Holstein (DE)
  • Département de Médecine Gériatrique, CHRU de Nancy and INSERM U1116, Université de Lorraine, Vandoeuvre-les-Nancy, France
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Inserm (FR)
  • National Yang Ming University (TW)
  • King's College London (GB)
  • Cardiff Metropolitan University (GB)
  • The University of Queensland (AU)
  • University of Pisa (IT)
  • University College London (GB)
  • Jagiellonian University (PL)
  • Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France
  • University of Cambridge (GB)
  • Pulse Wave Consulting, Saint Leu la Foret, France
  • Biomedical Engineering Unit, First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
  • IRCCS Istituto Auxologico Italiano (IT)
  • Dankook University (KR)
  • National and Kapodistrian University of Athens (GR)
  • Weill Cornell Medicine (US)
  • University of Perugia (IT)
  • Ghent University (BE)
  • Tokyo Medical University (JP)
  • University of Pennsylvania (US)
  • Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium
  • The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • AIT Austrian Institute of Technology GmbH (AT)
  • Klinikum Wels-Grieskirchen (AT)
Corresponding author
Sharman, James E.
Venue
European Heart Journal
Published
2017-01-30
Volume
38
Issue
37
Pages
2805-2812
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2585667310
Cited by
231
References
77
Citations by year
2026: 10 · 2025: 13 · 2024: 25 · 2023: 26 · 2022: 27 · 2021: 27 · 2020: 35 · 2019: 24 · 2018: 23 · 2017: 19
FWCI
18.12
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UTAS Research Repository (acceptedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion, cc-by-nc)
  • Research Online (University of Wollongong) (submittedVersion)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by-nc)
  • Cardiff Metropolitan Research Repository (Cardiff Metropolitan University) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
  • Apollo
Funders
  • National Institute for Health and Care Research (NF-SI-0515-10093)
  • British Heart Foundation (FS/12/8/29377, SP/14/8/31352)
  • High Blood Pressure Research Council of Australia
  • Servier
  • Menzies Institute for Medical Research
  • Institut Servier
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
Keywords
central blood pressure, non-invasive blood pressure measurement, device validation, applanation tonometry, generalized transfer function, cardiovascular risk assessment, protocol standardization
MeSH terms
Blood Pressure, Blood Pressure Determination, Cardiology, Congresses as Topic, Humans, Hypertension, Netherlands, Reference Standards, Societies, Medical, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization. https://app.cochat.ai/papers/10.1093/eurheartj/ehw632
The paper
Sharman, J. E., Avolio, A. P., Baulmann, J., Benetos, A., Blacher, J., Blizzard, C. L., Boutouyrie, P., Chen, C.-H., Chowienczyk, P., Cockcroft, J. R., Cruickshank, J. K., Ferreira, I., Ghiadoni, L., Hughes, A., Jankowski, P., Laurent, S., McDonnell, B. J., McEniery, C., Millasseau, S. C., . . . Vlachopoulos, C. (2017). Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw632

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.